US 6083503
Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection
expired A61KA61K38/2013A61K39/35
Quick answer
US patent 6083503 (Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic responses, and graft rejection) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/2013, A61K39/35, A61P, A61P37/06